simply_sim的个人主页 - 老虎社区

simply_sim

simply_sim

暂无个人介绍

IP属地：未知

5关注

16粉丝

0主题

0勋章

2021-12-27

Why?

Novavax shares dropped 8% in morning trading

2021-12-18

Like

Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list

2021-06-21

But don't see my stocks really....[傲娇]

抱歉，原内容已删除

2021-10-12

$Micron Technology(MU)$sigh

2021-09-28

$Micron Technology(MU)$premarket an indication of not so good results?

2021-12-28

Does that justify the daily declines? Won't investors be excited over the few new catalysts?

Why Novavax Stock Is Sinking Today

2021-12-27

Sigh

Singapore stocks open slightly lower on Monday; STI down 0.1%

2021-11-06

$Novavax(NVAX)$doesn't look good

2021-12-27

Novavac go!

抱歉，原内容已删除

2021-12-23

Woohoo

Novavax shares rose 5.56% in premarket trading.

2021-11-09

What happened?

@HKpoh:$扬子江船业(BS6.SI)$发生什么事🤔？？

2021-10-27

$MasterCard(MA)$dragged down by visa?

2021-10-06

$KEPPEL DC REIT(AJBU.SI)$what happened?

2021-06-19

Go dxcm go. [龇牙]

Dexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3586573341987690,"uuid":"3586573341987690","gmtCreate":1623479347958,"gmtModify":1626666866611,"name":"simply_sim","pinyin":"simplysimsimplysim","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":16,"headSize":5,"tweetSize":84,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.18%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":696831676,"gmtCreate":1640659361618,"gmtModify":1640659361842,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","listText":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","text":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696831676","repostId":"1187889461","repostType":4,"repost":{"id":"1187889461","pubTimestamp":1640657510,"share":"https://www.laohu8.com/m/news/1187889461?lang=&edition=full","pubTime":"2021-12-28 10:11","market":"us","language":"en","title":"Why Novavax Stock Is Sinking Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187889461","media":"Motley Fool","summary":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The com","content":"<p>What happened</p>\n<p>Shares of&nbsp;<b>Novavax</b>(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p>So what</p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p>Now what</p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Is Sinking Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Is Sinking Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 10:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187889461","content_text":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":943,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696310849,"gmtCreate":1640616693631,"gmtModify":1640616693922,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Why?","listText":"Why?","text":"Why?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696310849","repostId":"1103486686","repostType":4,"repost":{"id":"1103486686","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640616531,"share":"https://www.laohu8.com/m/news/1103486686?lang=&edition=full","pubTime":"2021-12-27 22:48","market":"us","language":"en","title":"Novavax shares dropped 8% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1103486686","media":"Tiger Newspress","summary":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","content":"<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p>\n<p><img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped 8% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped 8% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p>\n<p><img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103486686","content_text":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","news_type":1},"isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069967,"gmtCreate":1640576213852,"gmtModify":1640576338966,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696069967","repostId":"1134678244","repostType":4,"repost":{"id":"1134678244","pubTimestamp":1640570035,"share":"https://www.laohu8.com/m/news/1134678244?lang=&edition=full","pubTime":"2021-12-27 09:53","market":"sg","language":"en","title":"Singapore stocks open slightly lower on Monday; STI down 0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134678244","media":"Businesstimes","summary":"SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Stra","content":"<div>\n<p>SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Straits Times Index (STI) down 0.1 per cent or 2.01 points to 3,106.27 as at 9.03 am.\nGainers ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0\">Web Link</a>\n\n</div>\n","source":"lsy1607307803821","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore stocks open slightly lower on Monday; STI down 0.1%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore stocks open slightly lower on Monday; STI down 0.1%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0><strong>Businesstimes</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Straits Times Index (STI) down 0.1 per cent or 2.01 points to 3,106.27 as at 9.03 am.\nGainers ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134678244","content_text":"SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Straits Times Index (STI) down 0.1 per cent or 2.01 points to 3,106.27 as at 9.03 am.\nGainers outnumbered losers 70 to 36, after 57.4 million securities worth S$15 million changed hands.\nThe most active counter by volume was Hatten Land, which saw 32.4 million of its shares worth S$1.8 million traded as at 9.03 am. Its shares gained S$0.006 or 12.8 per cent to S$0.053.\nThe Catalist-listed Malaysia property developer on Monday said it has inked an agreement with Huawei International to jointly explore and develop business opportunities in renewable energy, data centres, cloud computing, enterprise intelligence and fintech infrastructure.\nAmong index stocks, CapitaLand Integrated Commercial Trust saw brisk trading, with 381,100 units worth S$760,000 changing hands. Its units were flat at S$1.99.\nST Engineering was also actively traded, with 201,600 shares worth S$750,000 changing hands. The counter was down S$0.02 or 0.5 per cent at S$3.72.\nThe trio of local banks were down in early trade. DBS fell S$0.05 or 0.2 per cent to S$32.56, UOB lost S$0.10 or 0.4 per cent to S$26.79, while OCBC slipped S$0.02 or 0.2 per cent to S$11.32.\nIn the US, markets were closed on Friday (Dec 24) for the Christmas holiday.\nMeanwhile, European shares closed lower in light holiday trading on Friday, following a recent rally in global shares on signs the Omicron variant might not derail the pace of economic recovery.\nThe pan-European Stoxx 600 index slipped 0.1 per cent to 483.01 in a shortened trading session ahead of Christmas. The benchmark added 1.9 per cent last week.\nElsewhere in Asia, Tokyo stocks opened slightly lower in thin holiday trade on Monday as fears linger over the potential impact of the Omicron variant.\nThe benchmark Nikkei 225 index dipped 0.1 per cent or 21.37 points to 28,761.22 in early trade, while the broader Topix index was down 0.1 per cent or 2.39 points at 1,984.39.","news_type":1},"isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069020,"gmtCreate":1640576187400,"gmtModify":1640576338772,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Novavac go!","listText":"Novavac go!","text":"Novavac go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696069020","repostId":"2194177711","repostType":4,"isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691745922,"gmtCreate":1640251620512,"gmtModify":1640251620735,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Woohoo&nbsp;","listText":"Woohoo&nbsp;","text":"Woohoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691745922","repostId":"1136917991","repostType":4,"repost":{"id":"1136917991","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640250865,"share":"https://www.laohu8.com/m/news/1136917991?lang=&edition=full","pubTime":"2021-12-23 17:14","market":"us","language":"en","title":"Novavax shares rose 5.56% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1136917991","media":"Tiger Newspress","summary":"Novavax shares rose 5.56% in premarket trading.Novavax Inc's COVID-19 vaccine is effective in genera","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5.56%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/620ebe5abb2f21c595c486e8ce143b28\" tg-width=\"710\" tg-height=\"588\" width=\"100%\" height=\"auto\">Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares rose 5.56% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares rose 5.56% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-23 17:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5.56%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/620ebe5abb2f21c595c486e8ce143b28\" tg-width=\"710\" tg-height=\"588\" width=\"100%\" height=\"auto\">Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136917991","content_text":"Novavax shares rose 5.56% in premarket trading.Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699208690,"gmtCreate":1639800700087,"gmtModify":1639800700312,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699208690","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1},"isVote":1,"tweetType":1,"viewCount":876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844582229,"gmtCreate":1636441127037,"gmtModify":1636441127391,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"What happened?","listText":"What happened?","text":"What happened?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844582229","repostId":"844277031","repostType":1,"repost":{"id":844277031,"gmtCreate":1636435957907,"gmtModify":1636435958916,"author":{"id":"4090651426001740","authorId":"4090651426001740","name":"HKpoh","avatar":"https://static.tigerbbs.com/c7e76b0a89262ef58fedef12ced230ca","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BS6.SI\">$扬子江船业(BS6.SI)$</a>发生什么事🤔？？","listText":"<a href=\"https://laohu8.com/S/BS6.SI\">$扬子江船业(BS6.SI)$</a>发生什么事🤔？？","text":"$扬子江船业(BS6.SI)$发生什么事🤔？？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844277031","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842664683,"gmtCreate":1636171472420,"gmtModify":1636171472748,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>doesn't look good","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>doesn't look good","text":"$Novavax(NVAX)$doesn't look good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842664683","isVote":1,"tweetType":1,"viewCount":885,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855803222,"gmtCreate":1635346455848,"gmtModify":1635346456553,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>dragged down by visa?","listText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>dragged down by visa?","text":"$MasterCard(MA)$dragged down by visa?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855803222","isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826448644,"gmtCreate":1634049347431,"gmtModify":1634049347792,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>sigh","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>sigh","text":"$Micron Technology(MU)$sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/826448644","isVote":1,"tweetType":1,"viewCount":772,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829203450,"gmtCreate":1633508099969,"gmtModify":1633508100314,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","text":"$KEPPEL DC REIT(AJBU.SI)$what happened?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829203450","isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862915798,"gmtCreate":1632828667637,"gmtModify":1632828667733,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>premarket an indication of not so good results?","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>premarket an indication of not so good results?","text":"$Micron Technology(MU)$premarket an indication of not so good results?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862915798","isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":167422106,"gmtCreate":1624282900405,"gmtModify":1634008451136,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"But don't see my stocks really....[傲娇]&nbsp;","listText":"But don't see my stocks really....[傲娇]&nbsp;","text":"But don't see my stocks really....[傲娇]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167422106","repostId":"1171968125","repostType":4,"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":165814140,"gmtCreate":1624115419680,"gmtModify":1634010571681,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Go dxcm go.&nbsp;[龇牙]&nbsp;","listText":"Go dxcm go.&nbsp;[龇牙]&nbsp;","text":"Go dxcm go. [龇牙]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165814140","repostId":"2143750394","repostType":2,"repost":{"id":"2143750394","pubTimestamp":1623770823,"share":"https://www.laohu8.com/m/news/2143750394?lang=&edition=full","pubTime":"2021-06-15 23:27","market":"us","language":"en","title":"Dexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia","url":"https://stock-news.laohu8.com/highlight/detail?id=2143750394","media":"Zacks","summary":"Dexcom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system","content":"<html><body><p><strong>Dexcom, Inc.</strong> DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system might now be eligible for provincial coverage in British Columbia, Canada through BC PharmaCare. Diabetics who are on intensive insulin therapy and above the age of two may be entitled to the coverage. Customers will now be able to pick up their Dexcom CGM supplies through a participating local pharmacy as part of the BC PharmaCare coverage program.</p>\n<p>For investors’ note, British Columbia joins the ranks of Yukon, Quebec and Saskatchewan to offer public coverage of CGM systems under provincial health plans. Moreover, Prince Edward Island and Manitoba have also recently announced funding plans based on their 2021 budget platforms.</p>\n<p>It should be noted that patients must meet the coverage criteria, be enrolled in eligible PharmaCare plans and meet any deductible requirements to be eligible for coverage in British Columbia.</p>\n<p>With the latest favorable coverage decision, Dexcom is expected to solidify its foothold in the global CGM business.</p>\n<h3>Significance of the Coverage</h3>\n<p>The Dexcom G6 CGM System comprises of a small wearable sensor with real-time alerts, including a predictive Urgent Low Soon alert. Thus, the Dexcom G6 can warn the user beforehand about hypoglycemia (lower than normal blood sugar level) during any time of the day.</p>\n<p>The CGM aids in better glycemic control (medical term referring to the typical levels of blood sugar in diabetics) for patients. It also gives physicians better insights into patients’ glucose levels and aids in making treatment decisions. Also, using a CGM may help avoid severe hypoglycemic episodes, thus lowering the number of visits to the emergency room.</p>\n<p>The coverage expansion is expected to boost accessibility to the CGM technology for diabetes management. It also recognizes the technology’s impact on those who depend on intensive insulin therapy to manage their type 1 and type 2 diabetes. Per management, the improved access to CGM is expected to positively impact all the diabetics’ lives across Canada.</p>\n<p>Per a field expert, better access to CGM technology elevates diabetes management for everyone in a patient’s circle of care.</p>\n<h3>Industry Prospects</h3>\n<p>Per a report by Grand View Research, the global CGM device market size was valued at $3,929.7 million in 2019 and is expected to reach $10.4 billion by 2027 at a CAGR of 12.7%. Factors like rising cases of diabetes and increasing adoption of CGM devices are likely to drive the market.</p>\n<p>Given the market potential, the latest coverage announcement is expected to provide a significant boost to Dexcom’s business globally.</p>\n<h3>Notable Developments</h3>\n<p>Of late, Dexcom has witnessed a few notable developments across its business.</p>\n<p>The company, during its first-quarter 2021 earnings call in April, reported solid revenue growth in both domestic and international markets. Dexcom also confirmed advancing the clinical and regulatory path for its next-generation G7 CGM system.</p>\n<p>The same month, Dexcom received Health Canada authorization for the Dexcom G6 CGM System, which is to be worn on the back of the upper arm by diabetics above the age of 18. Further in the month, the company announced that it is selling the Dexcom G6 CGM system directly throughout the Netherlands after the termination of its distribution collaboration with Zkope Healthcare.</p>\n<h3>Price Performance</h3>\n<p>Shares of the company have gained 4.1% in the past year compared with the industry’s 18.9% growth and the S&amp;P 500's 38.1% rise.</p>\n<p><img src=\"https://s1.yimg.com/uu/api/res/1.2/fCk3KcxJST0tLIOKcBr6BA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/zacks.com/91a6b328861e3ddee3e3d48fc4507428\"/><span>Image Source: Zacks Investment Research</span></p>\n<h3>Zacks Rank &amp; Key Picks</h3>\n<p>Currently, Dexcom carries a Zacks Rank #3 (Hold).</p>\n<p>Some better-ranked stocks from the broader medical space are <strong><a href=\"https://laohu8.com/S/VEEV\">Veeva Systems Inc.</a> </strong>VEEV, <strong><a href=\"https://laohu8.com/S/AMN\">AMN Healthcare Services Inc</a> </strong>AMN and <strong>National Vision Holdings, Inc. </strong>EYE.</p>\n<p>Veeva Systems’ long-term earnings growth rate is estimated at 15.8%. The company presently carries a Zacks Rank #2 (Buy). You can see <strong>the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.</strong></p>\n<p>AMN Healthcare’s long-term earnings growth rate is estimated at 6.5%. It currently carries a Zacks Rank #2.</p>\n<p>National Vision’s long-term earnings growth rate is estimated at 23%. It currently sports a Zacks Rank #1.</p>\n<h3>Zacks Names “Single Best Pick to Double”</h3>\n<p>From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks <a href=\"https://laohu8.com/S/AONE\">one</a> to have the most explosive upside of all.</p>\n<p>You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in <a href=\"https://laohu8.com/S/AONE.U\">one</a> year.</p>\n<p><strong>Free: See Our Top Stock and 4 Runners Up &gt;&gt;</strong></p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nDexCom, Inc. (DXCM) : Free Stock Analysis Report\n<br/> \n<br/>\nAMN Healthcare Services Inc (AMN) : Free Stock Analysis Report\n<br/> \n<br/>\nVeeva Systems Inc. (VEEV) : Free Stock Analysis Report\n<br/> \n<br/>\nNational Vision Holdings, Inc. (EYE) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.\n<br/> \n<br/>\nZacks Investment Research</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/dexcoms-dxcm-g6-cgm-system-152703879.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dexcom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system might now be eligible for provincial coverage in British Columbia, Canada through BC PharmaCare. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/dexcoms-dxcm-g6-cgm-system-152703879.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/o8bx9OFnjFuN_6YoOKEl6g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/2jf8ct.1e_03uWVPZd.cOw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/28545f4b6c3471390df30d387719fbdd","relate_stocks":{"DXCM":"德康医疗"},"source_url":"https://finance.yahoo.com/news/dexcoms-dxcm-g6-cgm-system-152703879.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143750394","content_text":"Dexcom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system might now be eligible for provincial coverage in British Columbia, Canada through BC PharmaCare. Diabetics who are on intensive insulin therapy and above the age of two may be entitled to the coverage. Customers will now be able to pick up their Dexcom CGM supplies through a participating local pharmacy as part of the BC PharmaCare coverage program.\nFor investors’ note, British Columbia joins the ranks of Yukon, Quebec and Saskatchewan to offer public coverage of CGM systems under provincial health plans. Moreover, Prince Edward Island and Manitoba have also recently announced funding plans based on their 2021 budget platforms.\nIt should be noted that patients must meet the coverage criteria, be enrolled in eligible PharmaCare plans and meet any deductible requirements to be eligible for coverage in British Columbia.\nWith the latest favorable coverage decision, Dexcom is expected to solidify its foothold in the global CGM business.\nSignificance of the Coverage\nThe Dexcom G6 CGM System comprises of a small wearable sensor with real-time alerts, including a predictive Urgent Low Soon alert. Thus, the Dexcom G6 can warn the user beforehand about hypoglycemia (lower than normal blood sugar level) during any time of the day.\nThe CGM aids in better glycemic control (medical term referring to the typical levels of blood sugar in diabetics) for patients. It also gives physicians better insights into patients’ glucose levels and aids in making treatment decisions. Also, using a CGM may help avoid severe hypoglycemic episodes, thus lowering the number of visits to the emergency room.\nThe coverage expansion is expected to boost accessibility to the CGM technology for diabetes management. It also recognizes the technology’s impact on those who depend on intensive insulin therapy to manage their type 1 and type 2 diabetes. Per management, the improved access to CGM is expected to positively impact all the diabetics’ lives across Canada.\nPer a field expert, better access to CGM technology elevates diabetes management for everyone in a patient’s circle of care.\nIndustry Prospects\nPer a report by Grand View Research, the global CGM device market size was valued at $3,929.7 million in 2019 and is expected to reach $10.4 billion by 2027 at a CAGR of 12.7%. Factors like rising cases of diabetes and increasing adoption of CGM devices are likely to drive the market.\nGiven the market potential, the latest coverage announcement is expected to provide a significant boost to Dexcom’s business globally.\nNotable Developments\nOf late, Dexcom has witnessed a few notable developments across its business.\nThe company, during its first-quarter 2021 earnings call in April, reported solid revenue growth in both domestic and international markets. Dexcom also confirmed advancing the clinical and regulatory path for its next-generation G7 CGM system.\nThe same month, Dexcom received Health Canada authorization for the Dexcom G6 CGM System, which is to be worn on the back of the upper arm by diabetics above the age of 18. Further in the month, the company announced that it is selling the Dexcom G6 CGM system directly throughout the Netherlands after the termination of its distribution collaboration with Zkope Healthcare.\nPrice Performance\nShares of the company have gained 4.1% in the past year compared with the industry’s 18.9% growth and the S&P 500's 38.1% rise.\nImage Source: Zacks Investment Research\nZacks Rank & Key Picks\nCurrently, Dexcom carries a Zacks Rank #3 (Hold).\nSome better-ranked stocks from the broader medical space are Veeva Systems Inc. VEEV, AMN Healthcare Services Inc AMN and National Vision Holdings, Inc. EYE.\nVeeva Systems’ long-term earnings growth rate is estimated at 15.8%. The company presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.\nAMN Healthcare’s long-term earnings growth rate is estimated at 6.5%. It currently carries a Zacks Rank #2.\nNational Vision’s long-term earnings growth rate is estimated at 23%. It currently sports a Zacks Rank #1.\nZacks Names “Single Best Pick to Double”\nFrom thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.\nYou know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.\nFree: See Our Top Stock and 4 Runners Up >>\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nDexCom, Inc. (DXCM) : Free Stock Analysis Report\n \n\nAMN Healthcare Services Inc (AMN) : Free Stock Analysis Report\n \n\nVeeva Systems Inc. (VEEV) : Free Stock Analysis Report\n \n\nNational Vision Holdings, Inc. (EYE) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.\n \n\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":696310849,"gmtCreate":1640616693631,"gmtModify":1640616693922,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Why?","listText":"Why?","text":"Why?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696310849","repostId":"1103486686","repostType":4,"repost":{"id":"1103486686","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640616531,"share":"https://www.laohu8.com/m/news/1103486686?lang=&edition=full","pubTime":"2021-12-27 22:48","market":"us","language":"en","title":"Novavax shares dropped 8% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1103486686","media":"Tiger Newspress","summary":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","content":"<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p>\n<p><img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped 8% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped 8% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 22:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.</p>\n<p><img src=\"https://static.tigerbbs.com/d6627c5ec391aa02c9ec15dfc36c8f87\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103486686","content_text":"Novavax shares dropped 8% in morning trading.The stock fell 3.3% in the previous trading day.","news_type":1},"isVote":1,"tweetType":1,"viewCount":860,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699208690,"gmtCreate":1639800700087,"gmtModify":1639800700312,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699208690","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1},"isVote":1,"tweetType":1,"viewCount":876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":167422106,"gmtCreate":1624282900405,"gmtModify":1634008451136,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"But don't see my stocks really....[傲娇]&nbsp;","listText":"But don't see my stocks really....[傲娇]&nbsp;","text":"But don't see my stocks really....[傲娇]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167422106","repostId":"1171968125","repostType":4,"isVote":1,"tweetType":1,"viewCount":216,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826448644,"gmtCreate":1634049347431,"gmtModify":1634049347792,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>sigh","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>sigh","text":"$Micron Technology(MU)$sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/826448644","isVote":1,"tweetType":1,"viewCount":772,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862915798,"gmtCreate":1632828667637,"gmtModify":1632828667733,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>premarket an indication of not so good results?","listText":"<a href=\"https://laohu8.com/S/MU\">$Micron Technology(MU)$</a>premarket an indication of not so good results?","text":"$Micron Technology(MU)$premarket an indication of not so good results?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862915798","isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696831676,"gmtCreate":1640659361618,"gmtModify":1640659361842,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","listText":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","text":"Does that justify the daily declines? Won't investors be excited over the few new catalysts?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696831676","repostId":"1187889461","repostType":4,"repost":{"id":"1187889461","pubTimestamp":1640657510,"share":"https://www.laohu8.com/m/news/1187889461?lang=&edition=full","pubTime":"2021-12-28 10:11","market":"us","language":"en","title":"Why Novavax Stock Is Sinking Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187889461","media":"Motley Fool","summary":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The com","content":"<p>What happened</p>\n<p>Shares of&nbsp;<b>Novavax</b>(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p>So what</p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p>Now what</p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Novavax Stock Is Sinking Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Novavax Stock Is Sinking Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 10:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/12/27/why-novavax-stock-is-sinking-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187889461","content_text":"What happened\nShares of Novavax(NASDAQ:NVAX)were sinking 9.6% as of 11:47 a.m. ET on Monday. The company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":943,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069967,"gmtCreate":1640576213852,"gmtModify":1640576338966,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Sigh","listText":"Sigh","text":"Sigh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696069967","repostId":"1134678244","repostType":4,"repost":{"id":"1134678244","pubTimestamp":1640570035,"share":"https://www.laohu8.com/m/news/1134678244?lang=&edition=full","pubTime":"2021-12-27 09:53","market":"sg","language":"en","title":"Singapore stocks open slightly lower on Monday; STI down 0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134678244","media":"Businesstimes","summary":"SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Stra","content":"<div>\n<p>SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Straits Times Index (STI) down 0.1 per cent or 2.01 points to 3,106.27 as at 9.03 am.\nGainers ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0\">Web Link</a>\n\n</div>\n","source":"lsy1607307803821","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore stocks open slightly lower on Monday; STI down 0.1%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore stocks open slightly lower on Monday; STI down 0.1%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0><strong>Businesstimes</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Straits Times Index (STI) down 0.1 per cent or 2.01 points to 3,106.27 as at 9.03 am.\nGainers ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.businesstimes.com.sg/stocks/singapore-stocks-open-slightly-lower-on-monday-sti-down-01-0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134678244","content_text":"SINGAPORE shares opened slightly lower on Monday (Dec 27) after the Christmas weekend, with the Straits Times Index (STI) down 0.1 per cent or 2.01 points to 3,106.27 as at 9.03 am.\nGainers outnumbered losers 70 to 36, after 57.4 million securities worth S$15 million changed hands.\nThe most active counter by volume was Hatten Land, which saw 32.4 million of its shares worth S$1.8 million traded as at 9.03 am. Its shares gained S$0.006 or 12.8 per cent to S$0.053.\nThe Catalist-listed Malaysia property developer on Monday said it has inked an agreement with Huawei International to jointly explore and develop business opportunities in renewable energy, data centres, cloud computing, enterprise intelligence and fintech infrastructure.\nAmong index stocks, CapitaLand Integrated Commercial Trust saw brisk trading, with 381,100 units worth S$760,000 changing hands. Its units were flat at S$1.99.\nST Engineering was also actively traded, with 201,600 shares worth S$750,000 changing hands. The counter was down S$0.02 or 0.5 per cent at S$3.72.\nThe trio of local banks were down in early trade. DBS fell S$0.05 or 0.2 per cent to S$32.56, UOB lost S$0.10 or 0.4 per cent to S$26.79, while OCBC slipped S$0.02 or 0.2 per cent to S$11.32.\nIn the US, markets were closed on Friday (Dec 24) for the Christmas holiday.\nMeanwhile, European shares closed lower in light holiday trading on Friday, following a recent rally in global shares on signs the Omicron variant might not derail the pace of economic recovery.\nThe pan-European Stoxx 600 index slipped 0.1 per cent to 483.01 in a shortened trading session ahead of Christmas. The benchmark added 1.9 per cent last week.\nElsewhere in Asia, Tokyo stocks opened slightly lower in thin holiday trade on Monday as fears linger over the potential impact of the Omicron variant.\nThe benchmark Nikkei 225 index dipped 0.1 per cent or 21.37 points to 28,761.22 in early trade, while the broader Topix index was down 0.1 per cent or 2.39 points at 1,984.39.","news_type":1},"isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842664683,"gmtCreate":1636171472420,"gmtModify":1636171472748,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>doesn't look good","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>doesn't look good","text":"$Novavax(NVAX)$doesn't look good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842664683","isVote":1,"tweetType":1,"viewCount":885,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696069020,"gmtCreate":1640576187400,"gmtModify":1640576338772,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Novavac go!","listText":"Novavac go!","text":"Novavac go!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696069020","repostId":"2194177711","repostType":4,"isVote":1,"tweetType":1,"viewCount":651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691745922,"gmtCreate":1640251620512,"gmtModify":1640251620735,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Woohoo&nbsp;","listText":"Woohoo&nbsp;","text":"Woohoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691745922","repostId":"1136917991","repostType":4,"repost":{"id":"1136917991","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640250865,"share":"https://www.laohu8.com/m/news/1136917991?lang=&edition=full","pubTime":"2021-12-23 17:14","market":"us","language":"en","title":"Novavax shares rose 5.56% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1136917991","media":"Tiger Newspress","summary":"Novavax shares rose 5.56% in premarket trading.Novavax Inc's COVID-19 vaccine is effective in genera","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5.56%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/620ebe5abb2f21c595c486e8ce143b28\" tg-width=\"710\" tg-height=\"588\" width=\"100%\" height=\"auto\">Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares rose 5.56% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares rose 5.56% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-23 17:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5.56%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/620ebe5abb2f21c595c486e8ce143b28\" tg-width=\"710\" tg-height=\"588\" width=\"100%\" height=\"auto\">Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136917991","content_text":"Novavax shares rose 5.56% in premarket trading.Novavax Inc's COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to early data published on Wednesday, suggesting that the U.S. drugmaker's existing COVID-19 vaccine can help combat the new Omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":666,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844582229,"gmtCreate":1636441127037,"gmtModify":1636441127391,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"What happened?","listText":"What happened?","text":"What happened?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844582229","repostId":"844277031","repostType":1,"repost":{"id":844277031,"gmtCreate":1636435957907,"gmtModify":1636435958916,"author":{"id":"4090651426001740","authorId":"4090651426001740","name":"HKpoh","avatar":"https://static.tigerbbs.com/c7e76b0a89262ef58fedef12ced230ca","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BS6.SI\">$扬子江船业(BS6.SI)$</a>发生什么事🤔？？","listText":"<a href=\"https://laohu8.com/S/BS6.SI\">$扬子江船业(BS6.SI)$</a>发生什么事🤔？？","text":"$扬子江船业(BS6.SI)$发生什么事🤔？？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844277031","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855803222,"gmtCreate":1635346455848,"gmtModify":1635346456553,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>dragged down by visa?","listText":"<a href=\"https://laohu8.com/S/MA\">$MasterCard(MA)$</a>dragged down by visa?","text":"$MasterCard(MA)$dragged down by visa?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855803222","isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829203450,"gmtCreate":1633508099969,"gmtModify":1633508100314,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","listText":"<a href=\"https://laohu8.com/S/AJBU.SI\">$KEPPEL DC REIT(AJBU.SI)$</a>what happened?","text":"$KEPPEL DC REIT(AJBU.SI)$what happened?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829203450","isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":165814140,"gmtCreate":1624115419680,"gmtModify":1634010571681,"author":{"id":"3586573341987690","authorId":"3586573341987690","name":"simply_sim","avatar":"https://static.tigerbbs.com/e7c3058052acb2ec216ce2320fbd48da","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Go dxcm go.&nbsp;[龇牙]&nbsp;","listText":"Go dxcm go.&nbsp;[龇牙]&nbsp;","text":"Go dxcm go. [龇牙]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165814140","repostId":"2143750394","repostType":2,"repost":{"id":"2143750394","pubTimestamp":1623770823,"share":"https://www.laohu8.com/m/news/2143750394?lang=&edition=full","pubTime":"2021-06-15 23:27","market":"us","language":"en","title":"Dexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia","url":"https://stock-news.laohu8.com/highlight/detail?id=2143750394","media":"Zacks","summary":"Dexcom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system","content":"<html><body><p><strong>Dexcom, Inc.</strong> DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system might now be eligible for provincial coverage in British Columbia, Canada through BC PharmaCare. Diabetics who are on intensive insulin therapy and above the age of two may be entitled to the coverage. Customers will now be able to pick up their Dexcom CGM supplies through a participating local pharmacy as part of the BC PharmaCare coverage program.</p>\n<p>For investors’ note, British Columbia joins the ranks of Yukon, Quebec and Saskatchewan to offer public coverage of CGM systems under provincial health plans. Moreover, Prince Edward Island and Manitoba have also recently announced funding plans based on their 2021 budget platforms.</p>\n<p>It should be noted that patients must meet the coverage criteria, be enrolled in eligible PharmaCare plans and meet any deductible requirements to be eligible for coverage in British Columbia.</p>\n<p>With the latest favorable coverage decision, Dexcom is expected to solidify its foothold in the global CGM business.</p>\n<h3>Significance of the Coverage</h3>\n<p>The Dexcom G6 CGM System comprises of a small wearable sensor with real-time alerts, including a predictive Urgent Low Soon alert. Thus, the Dexcom G6 can warn the user beforehand about hypoglycemia (lower than normal blood sugar level) during any time of the day.</p>\n<p>The CGM aids in better glycemic control (medical term referring to the typical levels of blood sugar in diabetics) for patients. It also gives physicians better insights into patients’ glucose levels and aids in making treatment decisions. Also, using a CGM may help avoid severe hypoglycemic episodes, thus lowering the number of visits to the emergency room.</p>\n<p>The coverage expansion is expected to boost accessibility to the CGM technology for diabetes management. It also recognizes the technology’s impact on those who depend on intensive insulin therapy to manage their type 1 and type 2 diabetes. Per management, the improved access to CGM is expected to positively impact all the diabetics’ lives across Canada.</p>\n<p>Per a field expert, better access to CGM technology elevates diabetes management for everyone in a patient’s circle of care.</p>\n<h3>Industry Prospects</h3>\n<p>Per a report by Grand View Research, the global CGM device market size was valued at $3,929.7 million in 2019 and is expected to reach $10.4 billion by 2027 at a CAGR of 12.7%. Factors like rising cases of diabetes and increasing adoption of CGM devices are likely to drive the market.</p>\n<p>Given the market potential, the latest coverage announcement is expected to provide a significant boost to Dexcom’s business globally.</p>\n<h3>Notable Developments</h3>\n<p>Of late, Dexcom has witnessed a few notable developments across its business.</p>\n<p>The company, during its first-quarter 2021 earnings call in April, reported solid revenue growth in both domestic and international markets. Dexcom also confirmed advancing the clinical and regulatory path for its next-generation G7 CGM system.</p>\n<p>The same month, Dexcom received Health Canada authorization for the Dexcom G6 CGM System, which is to be worn on the back of the upper arm by diabetics above the age of 18. Further in the month, the company announced that it is selling the Dexcom G6 CGM system directly throughout the Netherlands after the termination of its distribution collaboration with Zkope Healthcare.</p>\n<h3>Price Performance</h3>\n<p>Shares of the company have gained 4.1% in the past year compared with the industry’s 18.9% growth and the S&amp;P 500's 38.1% rise.</p>\n<p><img src=\"https://s1.yimg.com/uu/api/res/1.2/fCk3KcxJST0tLIOKcBr6BA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/zacks.com/91a6b328861e3ddee3e3d48fc4507428\"/><span>Image Source: Zacks Investment Research</span></p>\n<h3>Zacks Rank &amp; Key Picks</h3>\n<p>Currently, Dexcom carries a Zacks Rank #3 (Hold).</p>\n<p>Some better-ranked stocks from the broader medical space are <strong><a href=\"https://laohu8.com/S/VEEV\">Veeva Systems Inc.</a> </strong>VEEV, <strong><a href=\"https://laohu8.com/S/AMN\">AMN Healthcare Services Inc</a> </strong>AMN and <strong>National Vision Holdings, Inc. </strong>EYE.</p>\n<p>Veeva Systems’ long-term earnings growth rate is estimated at 15.8%. The company presently carries a Zacks Rank #2 (Buy). You can see <strong>the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.</strong></p>\n<p>AMN Healthcare’s long-term earnings growth rate is estimated at 6.5%. It currently carries a Zacks Rank #2.</p>\n<p>National Vision’s long-term earnings growth rate is estimated at 23%. It currently sports a Zacks Rank #1.</p>\n<h3>Zacks Names “Single Best Pick to Double”</h3>\n<p>From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks <a href=\"https://laohu8.com/S/AONE\">one</a> to have the most explosive upside of all.</p>\n<p>You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in <a href=\"https://laohu8.com/S/AONE.U\">one</a> year.</p>\n<p><strong>Free: See Our Top Stock and 4 Runners Up &gt;&gt;</strong></p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nDexCom, Inc. (DXCM) : Free Stock Analysis Report\n<br/> \n<br/>\nAMN Healthcare Services Inc (AMN) : Free Stock Analysis Report\n<br/> \n<br/>\nVeeva Systems Inc. (VEEV) : Free Stock Analysis Report\n<br/> \n<br/>\nNational Vision Holdings, Inc. (EYE) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.\n<br/> \n<br/>\nZacks Investment Research</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDexcom's (DXCM) G6 CGM System Gets Coverage in British Columbia\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/dexcoms-dxcm-g6-cgm-system-152703879.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dexcom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system might now be eligible for provincial coverage in British Columbia, Canada through BC PharmaCare. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/dexcoms-dxcm-g6-cgm-system-152703879.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/o8bx9OFnjFuN_6YoOKEl6g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/2jf8ct.1e_03uWVPZd.cOw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/28545f4b6c3471390df30d387719fbdd","relate_stocks":{"DXCM":"德康医疗"},"source_url":"https://finance.yahoo.com/news/dexcoms-dxcm-g6-cgm-system-152703879.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143750394","content_text":"Dexcom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (“CGM”) system might now be eligible for provincial coverage in British Columbia, Canada through BC PharmaCare. Diabetics who are on intensive insulin therapy and above the age of two may be entitled to the coverage. Customers will now be able to pick up their Dexcom CGM supplies through a participating local pharmacy as part of the BC PharmaCare coverage program.\nFor investors’ note, British Columbia joins the ranks of Yukon, Quebec and Saskatchewan to offer public coverage of CGM systems under provincial health plans. Moreover, Prince Edward Island and Manitoba have also recently announced funding plans based on their 2021 budget platforms.\nIt should be noted that patients must meet the coverage criteria, be enrolled in eligible PharmaCare plans and meet any deductible requirements to be eligible for coverage in British Columbia.\nWith the latest favorable coverage decision, Dexcom is expected to solidify its foothold in the global CGM business.\nSignificance of the Coverage\nThe Dexcom G6 CGM System comprises of a small wearable sensor with real-time alerts, including a predictive Urgent Low Soon alert. Thus, the Dexcom G6 can warn the user beforehand about hypoglycemia (lower than normal blood sugar level) during any time of the day.\nThe CGM aids in better glycemic control (medical term referring to the typical levels of blood sugar in diabetics) for patients. It also gives physicians better insights into patients’ glucose levels and aids in making treatment decisions. Also, using a CGM may help avoid severe hypoglycemic episodes, thus lowering the number of visits to the emergency room.\nThe coverage expansion is expected to boost accessibility to the CGM technology for diabetes management. It also recognizes the technology’s impact on those who depend on intensive insulin therapy to manage their type 1 and type 2 diabetes. Per management, the improved access to CGM is expected to positively impact all the diabetics’ lives across Canada.\nPer a field expert, better access to CGM technology elevates diabetes management for everyone in a patient’s circle of care.\nIndustry Prospects\nPer a report by Grand View Research, the global CGM device market size was valued at $3,929.7 million in 2019 and is expected to reach $10.4 billion by 2027 at a CAGR of 12.7%. Factors like rising cases of diabetes and increasing adoption of CGM devices are likely to drive the market.\nGiven the market potential, the latest coverage announcement is expected to provide a significant boost to Dexcom’s business globally.\nNotable Developments\nOf late, Dexcom has witnessed a few notable developments across its business.\nThe company, during its first-quarter 2021 earnings call in April, reported solid revenue growth in both domestic and international markets. Dexcom also confirmed advancing the clinical and regulatory path for its next-generation G7 CGM system.\nThe same month, Dexcom received Health Canada authorization for the Dexcom G6 CGM System, which is to be worn on the back of the upper arm by diabetics above the age of 18. Further in the month, the company announced that it is selling the Dexcom G6 CGM system directly throughout the Netherlands after the termination of its distribution collaboration with Zkope Healthcare.\nPrice Performance\nShares of the company have gained 4.1% in the past year compared with the industry’s 18.9% growth and the S&P 500's 38.1% rise.\nImage Source: Zacks Investment Research\nZacks Rank & Key Picks\nCurrently, Dexcom carries a Zacks Rank #3 (Hold).\nSome better-ranked stocks from the broader medical space are Veeva Systems Inc. VEEV, AMN Healthcare Services Inc AMN and National Vision Holdings, Inc. EYE.\nVeeva Systems’ long-term earnings growth rate is estimated at 15.8%. The company presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.\nAMN Healthcare’s long-term earnings growth rate is estimated at 6.5%. It currently carries a Zacks Rank #2.\nNational Vision’s long-term earnings growth rate is estimated at 23%. It currently sports a Zacks Rank #1.\nZacks Names “Single Best Pick to Double”\nFrom thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.\nYou know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.\nFree: See Our Top Stock and 4 Runners Up >>\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nDexCom, Inc. (DXCM) : Free Stock Analysis Report\n \n\nAMN Healthcare Services Inc (AMN) : Free Stock Analysis Report\n \n\nVeeva Systems Inc. (VEEV) : Free Stock Analysis Report\n \n\nNational Vision Holdings, Inc. (EYE) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.\n \n\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}